Experts debate TSH threshold for levothyroxine use in pregnancy
A published debate examines differing views on when to initiate levothyroxine for pregnant women with TSH concentrations between 2.5 and 10 mIU/L, following recent guidelines that raised the treatment threshold to TSH 4.0 mIU/L or higher with normal thyroxine, and that recommend against treatment between 2.5 and 4.0 mIU/L. One clinician argues individualized treatment may still be reasonable for select women with TSH 2.5-4.0 mIU/L and supports considering treatment for TSH 4.0-10.0 mIU/L, citing biological heterogeneity and evidence gaps, while the other argues against routine treatment in this range, citing uncertain benefit and risk of overtreatment.
Most relevant for: Clinicians managing pregnant women with mild thyroid dysfunction, particularly subclinical hypothyroidism identified in the first trimester.
Read the original at The Journal of Clinical Endocrinology & MetabolismSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More endocrinology updates
- Lower GDM diagnostic thresholds raise diagnoses without improving short-term outcomesOct 30, 2026
- Review reappraises menopausal hormone therapy safety, emphasizes timing and formulationOct 23, 2026
- 2025 ATA thyroglobulin cutoff may miss recurrences in higher-risk DTCOct 13, 2026
- ADA-EASD 2026 consensus favors earlier SGLT2/GLP-1 use in type 2 diabetesOct 2, 2026
- Lean MASLD shows milder liver histology but similar clinical outcomesSep 30, 2026